Harmonising the measurement of neutralising antibodies against chikungunya virus: a path forward for licensing of new vaccines?

IF 20.9 1区生物学 Q1 INFECTIOUS DISEASES

Lancet Microbe Pub Date : 2024-09-01 Epub Date: 2024-05-15 DOI:10.1016/S2666-5247(24)00097-1

Sally A Baylis, Ivana Knezevic, Neil M Almond

引用次数: 0

查看原文本刊更多论文

统一基孔肯雅病毒中和抗体的测量方法：新疫苗许可的前进之路？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Microbe Multiple-

CiteScore

27.20

自引率

0.80%

发文量

278

审稿时长

6 weeks

期刊介绍： The Lancet Microbe is a gold open access journal committed to publishing content relevant to clinical microbiologists worldwide, with a focus on studies that advance clinical understanding, challenge the status quo, and advocate change in health policy.